[Immunization against human malaria: present knowledge]. 1990

F Peyron, and B Oury, and Ambroise-Thomas
Laboratoire de Parasitologie et de Pathologie exotique, C.N.R.S. U.R.A. 1344, Centre collaborateur de l'Organisation Mondiale de la Santé, Faculté de Médecine, Université Joseph Fourier, La Tronche.

The authors review different aspects of immunization against malaria according to the different stages of the parasitic cycle of Plasmodium falciparum: sporozoite vaccine preventing organism infestation, merozoïte vaccine and gametocyte vaccines preventing the accomplishment of the sexual cycle. Progress of molecular biology and better knowledge of cellular immunity provide some prospects regarding parasitic vaccinology, thanks to genetic engineering. Recombinant vaccines in vitro, in vivo and synthetized are under study and provide the best prospects regarding immunization against human malaria.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D005818 Genetic Engineering Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. Genetic Intervention,Engineering, Genetic,Intervention, Genetic,Genetic Interventions,Interventions, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic

Related Publications

F Peyron, and B Oury, and Ambroise-Thomas
January 1976, Bulletin of the World Health Organization,
F Peyron, and B Oury, and Ambroise-Thomas
May 2012, La Revue du praticien,
F Peyron, and B Oury, and Ambroise-Thomas
January 1964, The American journal of tropical medicine and hygiene,
F Peyron, and B Oury, and Ambroise-Thomas
January 1947, Military surgeon,
F Peyron, and B Oury, and Ambroise-Thomas
December 2012, Nature medicine,
F Peyron, and B Oury, and Ambroise-Thomas
January 1972, Transactions of the Royal Society of Tropical Medicine and Hygiene,
F Peyron, and B Oury, and Ambroise-Thomas
January 1964, The American journal of tropical medicine and hygiene,
F Peyron, and B Oury, and Ambroise-Thomas
January 1964, The American journal of tropical medicine and hygiene,
F Peyron, and B Oury, and Ambroise-Thomas
January 1953, Transactions of the American Neurological Association,
F Peyron, and B Oury, and Ambroise-Thomas
February 1954, Connecticut state medical journal,
Copied contents to your clipboard!